These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19088124)

  • 1. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
    Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
    Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
    Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
    Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a large Italian family harbouring a Krit1/CCM1 mutation.
    Pileggi S; Buscone S; Ricci C; Patrosso MC; Marocchi A; Brunori P; Battistini S; Penco S
    J Mol Neurosci; 2010 Oct; 42(2):235-42. PubMed ID: 20419355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells.
    Riolo G; Ricci C; Battistini S
    Cells; 2021 Mar; 10(3):. PubMed ID: 33810005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
    Stockton RA; Shenkar R; Awad IA; Ginsberg MH
    J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postzygotic mosaicism in cerebral cavernous malformation.
    Rath M; Pagenstecher A; Hoischen A; Felbor U
    J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
    Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
    Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
    Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
    Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCM3 and cerebral cavernous malformation disease.
    Wang K; Zhou HJ; Wang M
    Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations.
    Galvão GDF; Trefilio LM; Salvio AL; da Silva EV; Alves-Leon SV; Fontes-Dantas FL; de Souza JM
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107947. PubMed ID: 39181174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
    Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
    Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
    Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
    J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions in CCM2 are a common cause of cerebral cavernous malformations.
    Liquori CL; Berg MJ; Squitieri F; Leedom TP; Ptacek L; Johnson EW; Marchuk DA
    Am J Hum Genet; 2007 Jan; 80(1):69-75. PubMed ID: 17160895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
    McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
    Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.